Ponatinib is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.<\/p>\n
A drug used to treat adults with certain types of chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia. It is used in patients whose cancer has the\u00a0T315I<\/em>\u00a0mutation or whose cancer cannot be treated with other tyrosine kinase inhibitors. It is also being studied in the treatment of other types of cancer. Ponatinib hydrochloride blocks BCR-ABL and other proteins, which may help keep cancer cells from growing and may kill them. It may also prevent the growth of new blood vessels that tumors need to grow. Ponatinib hydrochloride is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent.<\/p>\n Indian Pharma Network (IPN) Legitimate consultant and facilitator for Specialty drugs in India.<\/a> IPN, Delhi can assist you in connecting with prospective distributors, wholesalers, suppliers, and dealers of ICLUSIG (ponatinib) tablets<\/strong>. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.<\/p>\n Ponatinib tablets is “used to treat patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ ALL for whom no other tyrosine kinase inhibitor (TKI)<\/strong>“. ICLUSIG Tablets<\/strong> is a “prescription medicine”<\/strong>. It is available in “form and strength”<\/strong> Tablets: 15 mg and 45 mg. ICLUSIG Tablets\u00a0can be obtained in India upon request.<\/strong> Approval Date:<\/strong> 2012 If you have a prescription from a Registered Medical Practitioner (RMP),\u00a0IPN<\/a> in Delhi can assist you in obtaining access to genuine medication.\u00a0 Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cPonatinib tablets\u201d based on the information you provide.<\/p>\nWho is the supplier of Specialty drug in India?<\/h3>\n
ICLUSIG (ponatinib) tablets for oral use Initial U.S. Approval: 2012<\/h4>\n
Related posts for product review usage<\/h3>\n
\n
Ponatinib injection
\nfor subcutaneous use Initial U.S. Approval: 2012<\/h2>\n
\nTo inquire about the ICLUSIG (ponatinib) tablets\u201coffer price in India\u201d<\/strong>, \u201cshipping process\u201d<\/strong>, and the \u201cestimated time of availability in India\u201d<\/strong>, please get in touch at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.\u201d<\/p>\nFacts about your medicine<\/strong><\/h4>\n
\nProprietary Name:<\/strong> On Request
\nActive Ingredient(s):<\/strong> Ponatinib tablets
\nDosage Forms And Strengths:<\/strong>
\nManufacturer:<\/strong>
\nMedicine Approved By: –<\/strong> European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
\nSummary of FDA approved use on approval date:\u00a0<\/strong>Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n